Therapeutic Effects against Tissue Necrosis of Remote Ischemic Preconditioning Combined with Human Adipose-Derived Stem Cells in Random-Pattern Skin Flap Rat Models

Author(s):  
Chang Sik Pak ◽  
Soo Young Moon ◽  
Young Eun Lee ◽  
Hyo Jin Kang
2014 ◽  
Vol 29 (suppl 3) ◽  
pp. 02-05 ◽  
Author(s):  
Caio Vinicius Suartz ◽  
Silvana Gaiba ◽  
Jerônimo Pereira de França ◽  
Antonio Carlos Aloise ◽  
Lydia Masako Ferreira

2015 ◽  
Vol 26 (5) ◽  
pp. 1450-1455 ◽  
Author(s):  
Mustafa Hasdemir ◽  
Hakan Agir ◽  
Guler Gamze Eren ◽  
Maksut Gorkem Aksu ◽  
Murat Sahin Alagoz ◽  
...  

2012 ◽  
Vol 8 (3) ◽  
pp. 844-853 ◽  
Author(s):  
Matthias A. Reichenberger ◽  
Wolf Mueller ◽  
Amelia Schäfer ◽  
Sina Heimer ◽  
Uwe Leimer ◽  
...  

2020 ◽  
Vol 230 (1) ◽  
Author(s):  
Xin Fan ◽  
Kai Li ◽  
Luochen Zhu ◽  
Xin Deng ◽  
Ziqian Feng ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-26
Author(s):  
Jiaxin Zhang ◽  
Yuzhe Liu ◽  
Yutong Chen ◽  
Lei Yuan ◽  
He Liu ◽  
...  

Adipose-derived stem cells (ADSCs) can maintain self-renewal and enhanced multidifferentiation potential through the release of a variety of paracrine factors and extracellular vesicles, allowing them to repair damaged organs and tissues. Consequently, considerable attention has increasingly been paid to their application in tissue engineering and organ regeneration. Here, we provide a comprehensive overview of the current status of ADSC preparation, including harvesting, isolation, and identification. The advances in preclinical and clinical evidence-based ADSC therapy for bone, cartilage, myocardium, liver, and nervous system regeneration as well as skin wound healing are also summarized. Notably, the perspectives, potential challenges, and future directions for ADSC-related researches are discussed. We hope that this review can provide comprehensive and standardized guidelines for the safe and effective application of ADSCs to achieve predictable and desired therapeutic effects.


2008 ◽  
Vol 121 (1) ◽  
pp. 50-58 ◽  
Author(s):  
Feng Lu ◽  
Hiroshi Mizuno ◽  
Cagri A. Uysal ◽  
Xiaobo Cai ◽  
Rei Ogawa ◽  
...  

2020 ◽  
Author(s):  
Xiang Wan ◽  
Min-kai Xie ◽  
Huan Xu ◽  
Zi-wei Wei ◽  
Hai-jun Yao ◽  
...  

Abstract Rationale: Tissue engineering is a promising alternative for urethral reconstruction, and adipose-derived stem cells (ADSCs) are widely used as seeding cells. Hypoxia preconditioning can significantly enhance the therapeutic effects of ADSCs. The low oxygen tension of postoperative wound healing is inevitable and may facilitate the nutritional function of ADSCs. This study aimed to investigate if hypoxia preconditioned ADSCs, compared to normxia preconditioned ADSCs, combined with scaffold could better promote urethral reconstruction and exploring the underlying mechanism.Methods: In vitro, paracrine cytokines and secretomes that were secreted by hypoxia- or normoxia-preconditioned ADSCs were added to cultures of human umbilical vein endothelial cells (HUVECs) to measure their functions. In vivo, hypoxia- or normoxia-preconditioned ADSCs were seeded on a porous nanofibrous scaffold for urethral repair on a defect model in rabbits.Results: The in vitro results showed that hypoxia could enhance the secretion of VEGFA by ADSCs, and hypoxia-preconditioned ADSCs could enhance the viability, proliferation, migration, angiogenesis and glycolysis of HUVECs (p < 0.05). After silencing VEGFA, angiogenesis and glycolysis were significantly inhibited (p < 0.05). The in vivo results showed that compared to normoxia-preconditioned ADSCs, hypoxia-preconditioned ADSCs combined with scaffolds led to a larger urethral lumen diameter, preserved urethral morphology and enhanced angiogenesis (p < 0.05). Conclusions: Hypoxia preconditioning of ADSCs combined with scaffold could better promote urethral reconstruction by upregulating angiogenesis and glycolysis. Hypoxia-preconditioned ADSCs combined with novel scaffold may provide a promising alternative treatment for urethral reconstruction.


Sign in / Sign up

Export Citation Format

Share Document